|Articles|August 1, 2002

Pharmaceutical Executive

  • Pharmaceutical Executive-08-01-2002

East Meets West

Author(s)Sarah Houlton

Croatia's Pliva Pharmaceuticals is the first eastern European pharma company to make a US acquisition. Pliva paid $153 million for New Jersey-based Sobel Holdings,

Croatia's Pliva Pharmaceuticals is the first eastern European pharma company to make a US acquisition. Pliva paid $153 million for New Jersey-based Sobel Holdings, which owns Sidmak, a generics maker, and Odyssey, a specialty brand-name pharma company with products such as Urecholine (bethanechol) for non-obstructive urinary retention; Vivactil (protryptylline) and Surmontil (trimipramine) for depression; Antabuse (disulfiram) for alcohol abuse; Nystatin vaginal tablets (for candidiasis); and Custodol HTK solution for the preservation of donor organs.

In addition to the company's product rights and trademarks, the deal gives Pliva an established US distribution network and a product development and manufacturing plant in East Hanover, New Jersey.

Articles in this issue

over 24 years ago

Elan Hits Bottom

over 24 years ago

Go With the Flow

over 24 years ago

Drug Info War Heats Up

over 24 years ago

Not So NICE

over 24 years ago

Internet to the Rescue

over 24 years ago

Policing CRM Sampling

over 24 years ago

House Adopts Medicare Rx Benefit

Related to this article

Pharmaceutical Executive Daily
FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site for next-generation obesity treatments, and Parexel’s Stacy Hurt on how small protocol decisions can become enrollment and retention barriers.